• Advancing Translational Mycology: Mechanistic Insights an...

  2025-10-01

  This thought-leadership article explores the mechanistic underpinnings and translational potential of Naftifine HCl, an allylamine antifungal agent, in the context of sterol biosynthesis inhibition and fungal cell membrane disruption. Building on recent research into cell signaling and differentiation, it provides strategic guidance for researchers aiming to bridge basic mycological science with clinical innovation.

• Triptolide as a Precision Epigenetic Inhibitor: New Front...

  2025-09-30

  Explore the multi-layered mechanisms and research applications of Triptolide, a potent IL-2/MMP inhibitor, in cancer research and immune regulation. This article delves into advanced insights on CDK7-mediated RNAPII degradation and apoptosis induction, offering a distinct comparative analysis with established approaches.

• DAPI (hydrochloride): Decoding DNA Dynamics in Organoid H...

  2025-09-29

  Explore how DAPI (hydrochloride), a DNA-specific fluorescent probe, advances high-throughput screening and quantitative cell fate analysis in organoid systems. This article details unique mechanisms and protocols for integrating DAPI into scalable, multiplexed workflows.

• Filipin III: Revolutionizing Cholesterol Microdomain Anal...

  2025-09-28

  Explore how Filipin III, a cholesterol-binding fluorescent antibiotic, is transforming membrane cholesterol visualization and lipid raft research. This in-depth analysis uniquely examines Filipin III’s mechanistic specificity and its emerging role in dissecting cholesterol homeostasis in metabolic diseases.

• DMXAA (Vadimezan): Advanced Mechanisms and Translational ...

  2025-09-27

  Discover how DMXAA (Vadimezan, AS-1404) functions as a vascular disrupting agent for cancer research, with a focus on its integration of DT-diaphorase inhibition, VEGFR2 targeting, and synergy with immune normalization. This article uniquely explores translational strategies and the latest mechanistic insights for cancer biology research.

• EZ Cap™ Cas9 mRNA (m1Ψ): Unraveling the Molecular Determi...

  2025-09-26

  Explore how EZ Cap™ Cas9 mRNA (m1Ψ) leverages advanced mRNA modifications for precise, efficient genome editing in mammalian cells. This in-depth analysis uncovers the molecular interplay between mRNA design, nuclear export, and editing specificity, offering unique insights beyond standard application guides.

• Paclitaxel (Taxol): From Microtubule Stabilizer to Precis...

  2025-09-25

  Explore the distinct mechanisms and innovative research uses of Paclitaxel (Taxol), a leading microtubule polymer stabilizer in cancer research. This article reveals cutting-edge insights into its role in cell cycle arrest, advanced neuropathy models, and emerging precision therapies.

• Sulfo-NHS-SS-Biotin: Transforming Cleavable Biotinylation...

  2025-09-24

  Explore how Sulfo-NHS-SS-Biotin, a leading amine-reactive biotinylation reagent, uniquely enables reversible cell surface protein labeling and mechanistic proteostasis studies. This article delivers advanced insights beyond established protocols, highlighting novel applications in dissecting autophagy and protein degradation pathways.

• Sulfo-NHS-SS-Biotin Kit: Precision Tools for Cell Surface...

  2025-09-23

  Explore the scientific versatility of the Sulfo-NHS-SS-Biotin Kit, a water-soluble amine-reactive biotinylation reagent enabling reversible biotin labeling with disulfide cleavage. This article highlights its advanced applications in cell surface protein labeling and cutting-edge proteomic studies.

• br Mechanisms for regulation of intracellular cholesterol ho

  2025-03-03

  

  Mechanisms for regulation of intracellular cholesterol homeostasis Cells maintain intracellular free cholesterol levels and distribution within stringent tolerances by several mechanisms [55]: (1) uptake of native LDL (the major extracellular carrier of cholesterol) by LDL receptors and modified

• br ACK inhibitors Since ACK

  2025-03-03

  

  ACK1 inhibitors Since ACK1 activation is correlated with poor prognosis in various cancers, strong efforts are being directed by multiple groups towards developing highly potent and specific small molecule inhibitors targeting the ACK1 kinase. At least eight small molecule kinase inhibitors have

• br Material and methods br Results

  2025-03-01

  

  Material and methods Results Discussion Asparagine, arginine, leucine, methionine, and glutamine are the essential tmn for cancer cells and intensively investigated for the development of selective targeted therapeutics. Among them, asparagine depleting bacterial enzyme asparaginase is rati

• TAK-715 Acknowledgments br Introduction Pulmonary fibrosis P

  2025-03-01

  

  Acknowledgments Introduction Pulmonary fibrosis (PF) is a chronic, fibrosing interstitial pneumonia and a crushing disease that occurs as a result of a variety of lung injuries, including auto-immune, tuberculosis and traumatic insult [1], [2]. PF is characterized by the accumulation of extracel

• Circular dichroism CD provides useful

  2025-03-01

  

  Circular dichroism (CD) provides useful information about protein structure, the extent and rate of structural changes and ligand binding. CD is a form of light Pasireotide spectroscopy that measures differences in the absorbance of right- and left-circularly polarized light (rather than the common

• To our knowledge BAY has not progressed to clinical

  2025-03-01

  

  To our knowledge, BAY 60-6583 has not progressed to clinical development and remains to be the only ADORA2B agonist that has been developed.33, 34 Further development of similar compounds would be beneficial in future fibrosis research. One of the limitations of our study is being limited to in vit

14959 records 5/998 page Previous Next 12345 下5页 Last page